The focus of this venture is to create an anti-fungal system to battle onychomycosis, a fungal infection of the fingernails or toenails that results in nail thickening, roughness, and splitting. Nails infected by onychomycosis can become brittle as the infection progresses with the possibility of  pieces of the nail breaking or falling off. The infection itself is not life threatening, but if left untreated the skin can become inflamed and painful underneath and around the nailbed.

Our proprietary combination of actives and a novel delivery system will not only address the  fungus head-on, but also promote nail healing. R&D phase began in 2014 with commercialization targeted for 2016.

Back to Overview & Pipeline